このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

BICO Group マネジメント

マネジメント基準チェック /24

BICO Group'sの CEO はMaria Forssで、 Nov2023年に任命され、の在任期間は 1 年未満です。の年間総報酬はSEK 7.43Mで、 6.5%給与と93.5%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.057%を直接所有しており、その価値は$ 170.07K 。経営陣と取締役会の平均在任期間はそれぞれ1.3年と3.7年です。

主要情報

Maria Forss

最高経営責任者

kr7.4m

報酬総額

CEO給与比率	6.5%
CEO在任期間	less than a year
CEOの所有権	0.06%
経営陣の平均在職期間	1.3yrs
取締役会の平均在任期間	3.7yrs

経営陣の近況

Recent updates

CEO報酬分析

BICO Group の収益と比較して、Maria Forss の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	-kr2b
Dec 31 2023	kr7m	kr484k	-kr2b

報酬と市場: Mariaの総報酬 ($USD 712.42K ) は、 US市場 ($USD 1.62M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Mariaの報酬と会社の業績を比較するにはデータが不十分です。

CEO（最高経営責任者

Maria Forss (52 yo)

less than a year

在職期間

kr7,425,520

報酬

Ms. Maria Forss serves as President & CEO of BICO Group AB (publ) since November 20, 2023. She served as Senior Vice President of Consumables at Vitrolife AB (publ) since January 01, 2022 until August 2023...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Maria Forss	President & CEO	less than a year	kr7.43m	0.057% SEK 171.2k
Jacob Thordenberg	Group Chief Financial Officer	1.4yrs	データなし	0.026% SEK 78.7k
Marius Balger	Chief Operating Officer	1.3yrs	データなし	データなし
Asa Hillsten	Senior VP & Head of Investor Relations	no data	データなし	データなし
Lotta Bus	SVP, General Counsel	4.4yrs	データなし	0.0099% SEK 29.9k
Artur Aira	Head of Corporate Development and M&A	1.3yrs	kr150.00k	0% SEK 0
Catharina Nordlund	Global Head of Human Resources	less than a year	データなし	データなし
Itedale Redwan	Chief Scientific Officer - Bioprinting	no data	データなし	データなし
Niclas Emanuelsson	Head of Global Operations	4.4yrs	データなし	データなし
Holger Eickhoff	Senior VP & Business Area Director - Bioautomation	2.4yrs	データなし	データなし
Erica Bell	Senior VP & Chief People Officer	no data	データなし	データなし
Nicolas Gabriel-Robez	Chief Security Officer	no data	データなし	データなし

1.3yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: CLLK.Fの経営陣は経験豊富とはみなされません ( 1.3年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Rolf Classon	Independent Chairman of the Board	2.2yrs	kr650.00k	0.044% SEK 132.5k
Christian Wildmoser	Independent Director	4.5yrs	kr285.00k	0.45% SEK 1.4m
Robert Langer	Member of Scientific Advisory Board	3.6yrs	データなし	データなし
Helena Skantorp	Independent Director	4.5yrs	kr350.00k	0.0057% SEK 17.1k
Ulrika Dellby	Independent Deputy Chairwoman	2.2yrs	kr510.00k	0.027% SEK 81.2k
Bengt Sjoholm	Independent Director	8.4yrs	kr285.00k	0.49% SEK 1.5m
Susan Tousi	Independent Director	2.6yrs	kr250.00k	データなし
Ali Khademhosseini	Member of Scientific Advisory Board	7.3yrs	データなし	データなし
Ido Amit	Member of Scientific Advisory Board	3.8yrs	データなし	データなし
Alexandra Gatzemeyer	Director	less than a year	データなし	データなし

3.7yrs

平均在職期間

69yo

平均年齢

経験豊富なボード: CLLK.Fの取締役会は経験豊富であると考えられます ( 3.7年の平均在任期間)。

BICO Group マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) Announces Chief Executive Officer Changes

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

Recent updates

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

BICO Group AB (publ) Announces Chief Executive Officer Changes

Beos Light Industrial Germany 1 Fund, a fund managed by BEOS AG agreed to acquire property on Wagner-Régeny-Straße 15 from BICO Group AB (publ) (OM:BICO) for €21 million.

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

BICO Group AB (publ) to Report Q1, 2023 Results on May 04, 2023

BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

BICO Group Announces Appointment of Nomination Committee 2023

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023

BICO Group Adds Åsa Hillsten as SVP and Head of IR

BICO Group AB (publ) (OM : BICO) acquired Allegro 3D for $11 million.

BICO (publ) Appoints Mikael Engblom as Interim CFO

BICO Group AB (Publ) Announces Board Appointments

BICO Reaches Beneficial and Sustainable Solution with Organovo

DISPENDIX, A BICO Company, Announces That the I.DOT HT Non-contact Dispenser and the L.DROP Liquid Handler will be introduced at SLAS 2022

BICO Group AB Announces Statement Regarding Counterclaims in Patent Lawsuit by Organovo Against Cellink

BICO Group AB (publ) (OM:BICO) agreed to acquire Biosero Llc.

BICO Group AB (publ) (OM:BICO) acquired all outstanding shares in Advanced BioMatrix, Inc. for $18 million.

CELLINK Receives Patent for Robotic Systems for Personalized and Automated Aesthetic Medical Procedures

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Discover Echo Inc.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Nanoscribe GmbH for approximately €37 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Nanoscribe GmbH for €34 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire MatTek Corporation for $68 million.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Ginolis Ltd from Verso Fund II of Verso Capital Oy, Finnvera plc and Innovestor Ventures for €65.7 million.

Cellink AB (publ) to Report Fiscal Year 2021 Results on Mar 16, 2022

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Ginolis Ltd for €70 million.

Cellink AB (publ) Announces Distribution Agreement Including New Products for Single-Cell RNA Sequencing and NGS Library Preparation

Cellink Announces Third Year Extension of Collaboration with A Global Biopharmaceutical Company for Drug Discovery

Cellink and Phasefocus Announces a Partnership to Bring Livecyte High Content Live Cell Imager to a Wider Audience

Cellink AB (publ) Elects Aristotelis Nastos as Member of the Board of Directors

CELLINK and Atelerix Team Up to Enable the Shipping At Room Temperature of Fragile 3D Bioprinted Constructs by the World's Bioprinting Community

CELLINK to Help Develop 3D Bioprinted Personalised Scaffolds for Tissue Regeneration of Ankle Joint S as Part of the Triankle Project

Cellink AB (publ) to Report Second Half, 2020 Results on Oct 22, 2020

Cellink AB (Publ) Announces Leaving Board of Directors for an Operational Role as Business Area Manager for the Bioprinting Business Unit

Cellink AB (publ) (OM:CLNK B) completed the acquisition of SCIENION AG from NRW.Bank Venture Fonds, L.P., managed by NRW.Bank, Investment Arm and other shareholders.

Cellink AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 945.99632 million.

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24